
Latest scientific findings give hope for people with incurable retinal degeneration
Humans rely dominantly on their eyesight. Losing vision means not being able to read, recognize faces or find objects. Macular degeneration is one of the major reasons for visual impairment, round the globe, close to 200 million people are affected. Photoreceptors in the retina are responsible to capture the light coming from the environment through the eye. Diseased photoreceptors lose their sensitivity to light, which can lead to impaired vision or even complete blindness. Scientists of the Institute of Molecular and Clinical Ophthalmology Basel (IOB) together with colleagues from the German Primate Center (DPZ) – Leibniz Institute for Primate Research in Göttingen have developed a completely new therapeutic approach based on gene therapy. They managed to activate degenerated photoreceptors using near-infrared light (Science).
The main cause of blindness in industrialized countries is the degeneration of photoreceptors, including age-related macular degeneration and retinitis pigmentosa. During the progression of degenerative photoreceptor diseases, light-sensitive and light-insensitive photoreceptor regions in the retina coexist. For example, macular degeneration patients lose vision in the central portion of their retina but retain peripheral eyesight.
Scientists have now succeeded in developing a new therapeutic approach to restore light sensitivity in degenerating retina without negatively affecting remaining vision. They were inspired by species found in nature, such as bats and snakes, that can localize near-infrared light emitted by the bodies of their preys. This is done by using heat-sensitive ion channels which are able to detect the heat of the near-infrared light. This enables the bats and snakes to superimpose thermal and visual images in the brain and thus react to their environment with greater precision. To equip retinal photoreceptors with near-infrared sensitivity, the researchers devised a three-component system. The first component contains engineered DNA that ensures that the gene coding for the heat-sensitive channel is only expressed in photoreceptors. The second component is a gold nanorod, a small particle, that efficiently absorbs near-infrared light. The third component is an antibody that ensures strong binding between the heat-sensitive channel expressed in photoreceptors and the gold nanorods that locally capture near-infrared light and locally release heat.
The researchers first tested their system in engineered mice with retinal degeneration, confirming that near-infrared light effectively excites photoreceptors and that this signal is transmitted to retinal ganglion cells, the latter representing the output of the retina towards higher visual centers in the brain. Next, they showed that stimulating the mouse eye with near-infrared light is also picked up by neurons in a brain area that is important for conscious vision, the primary visual cortex. They also designed a behavioral test in which untreated blind mice were not able to use near-infrared stimulation to learn a simple task whereas blind mice treated with the three-component system could perform the task related to near-infrared stimulus.
In collaboration with Arnold Szabo, a co-author of the paper and Assistant Professor at the Semmelweis University in Hungary, the researchers could test their new approach on human retinas that can be kept alive in culture medium for months, though blindness sets in a day or so after death by photoreceptors losing their ability to detect light. Experimental results showed that following treatment with the three-component gene therapy method, near-infrared light exposures reactivated the human retina’s visual circuitry.
“We believe that near-infrared stimulation is an important step towards providing useful vision to blind patients so that they can regain their ability to read or see faces”, says Daniel Hillier, head of the junior research group Visual Circuits and Repair at DPZ, and adds: “We want to give hope to blind people with these findings and will further intensify our research activities in this area here at DPZ within our main project, which focuses on the restoration of vision.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Gene therapy to restore vision
- Stargardt disease treatment gets FDA fast track
Nanoscope Therapeutics has announced the U.S. Food and Drug Administration has granted fast track designation for MCO-010.
- Nanoscope Therapeutics Receives Fast Track Designation By The FDA For MCO-010 For The Treatment Of Stargardt Disease
PRNewswire/ -- nanoscope therapeutics inc. , a clinical-stage biotechnology company developing gene therapies for retinal ...
- Meet these parents who are taking their children on world tour before they go blind
Canadian couple Edith Lemay and Sebastian Pelletier and their four children have been on the move, taking in sights and sounds as they tour the world. From the dunes in Namibia and valleys in ...
- University Of Houston Researchers Develop Gene Therapy For Blindness Causing Disease
A University of Houston researcher is expanding a method of gene therapy with the hopes it will restore vision loss in Usher Syndrome Type 2A (USH2A), a rare genetic disease. The National Eye ...
- Gene Therapy for Rare eye Disease
Researchers believe that gene therapy might help restore vision loss in Usher Syndrome Type 2A (USH2A), a rare genetic disorder. What is Usher Syndrome Type 2A, Rare Genetic Disease Usher Syndrome ...
Go deeper with Google Headlines on:
Gene therapy to restore vision
[google_news title=”” keyword=”infectious” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Incurable retinal degeneration
- Age-Related Macular Degeneration (AMD) Global Market Report 2022: Sector to Reach $14.6 Billion by 2028 at an 8.5% CAGR
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Age-Related Macular Degeneration (AMD) Market, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis ...
- Macular degeneration: what is it, and how can it be prevented?
It’s important for older people to go for regular eye checkups to stave off the onset of macular degeneration. (Envato Elements pic) One day, 60-year-old David came into the pharmacy and ...
- New Approaches To Macular Degeneration: Test Tube Retinas
Age-related macular degeneration is a leading cause of blindness and affects over 196 million people worldwide. Despite its prevalence, very little is known about the causes or mechanisms of this ...
- How 2 Eye Diseases Can Affect The Progress Of Age-Related Macular Degeneration
Many of us will experience some type of vision impairment as we age. Now researchers are learning about two conditions that contribute to it.
- What Test Can Help Diagnose Macular Degeneration?
Macular degeneration is a condition that is best diagnosed in-person by an eye doctor. An initial diagnosis might be made during a routine eye exam, but your doctor will likely perform additional ...
Go deeper with Google Headlines on:
Incurable retinal degeneration
[google_news title=”” keyword=”incurable retinal degeneration” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]